Global Structural Heart Devices Market Analysis & Forecast 2024-2034: Implications for Global Healthcare and Patient Outcomes

News provided by

Feb 01, 2024, 13:30 ET

DUBLIN, Feb. 1, 2024 /PRNewswire/ -- The "Global Structural Heart Devices Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.

Driven by increasing prevalence of cardiovascular diseases and technological advancements, the global structural heart devices market is projected to experience significant expansion, reaching USD 18.77 billion by 2034.

This rapidly evolving sector, marked by a compound annual growth rate (CAGR) of 9.48% from 2024 to 2034, is being propelled forward by rising demands for minimally invasive procedures and government initiatives aimed at cardiovascular disease management.

The rise in R&D activities, coupled with technological innovation in device design and materials, has given rise to a new wave of advanced solutions for structural heart disease, making way for a robust market landscape. In particular, heart valve devices have emerged as the leading product segment, generating the highest revenue within the market space due to substantial product approvals and a surge in novel therapeutic offerings.

Significant Market Segments Show Promising Growth Outlook

Fuelled by enhancements in medical technology and increased adoption rates, repair procedures continue to dominate the market in terms of revenue generation. Innovations like the MitraClip system underscore the market's commitment to refining minimally invasive approaches. Concurrently, the replacement procedure segment is anticipated to exhibit the fastest CAGR throughout the forecast period, supported by advancements in valve replacement technologies.

Pivotal indicators such as aortic valvular disease have steered the market with significant revenue contributions. However, pulmonary valvular disease is expected to be the fastest-growing segment, spurred by new system launches and increasing procedural volumes.

Hospitals remain essential end users, with their state-of-the-art medical facilities and expert surgical teams driving revenue growth. Nonetheless, ambulatory surgical centers are forecast to soar at the fastest CAGR, as they embrace modern technologies and patient preferences move towards outpatient care settings.

Geographical Highlights: North America Leads While Asia Pacific Shows Impressive Growth Trajectory

In terms of geographical distribution, North America is projected to maintain its revenue lead, supported by extensive healthcare spending and burgeoning R&D activities. Innovations such as 3D-GNC technology for heart navigation are emblematic of the region's commitment to cutting-edge healthcare solutions. The Asia Pacific region is on track to chart the most rapid growth rate, spurred by a burgeoning elderly population, rising incidence of cardiac disorders, and increased access to advanced structural heart devices.

Occluders & Delivery Systems
Heart Valve Devices
Annuloplasty Rings
Repair Procedures
Replacement Procedures
Atrial Septal Defects
Pulmonary Valvular Disease
Hospitals
Cardiac Centers
Ambulatory Surgical Centers

The regional market outlook is complemented by a robust analysis that spans the United States and Canada within North America, as well as an in-depth exploration of European markets including Germany, France, and the UK. The Asia Pacific report segments detail the contributions of China, Japan, India, and additional nations within the region, revealing a dynamic and varied structural heart devices landscape.

Implications for Global Healthcare and Patient Outcomes

The growth of the global structural heart devices market is indicative of a broader trend towards improving cardiovascular care and patient outcomes through innovative medical devices and procedures. As the market continues to evolve, it is likely to have a transformative impact on healthcare delivery, patient care standards, and the management of structural heart diseases worldwide.

This analysis provides a comprehensive view of the current state and future potential of the structural heart devices market, highlighting the importance of technological advancement and the increasing prevalence of heart conditions that require immediate attention. Stakeholders in the healthcare sector and interested parties are encouraged to explore the detailed findings of this report, which elucidates the trajectory of one of the most crucial health markets in the coming decade.

Report Segmentation: Structural Heart Devices Market

By Product

Occluders & Delivery Systems
Annuloplasty Rings
Heart Valve Devices
Other

By Procedure

Repair Procedure
Left Atrial Appendage Closure (LAAC)
Mitral Repair
Replacement Procedure
Transcatheter Aortic Valve Replacement (TAVR)
Surgical Aortic Valve Replacement (SAVR)))

By Indication

Pulmonary Valvular Disease
Atrial Septal Defects
Patent Foramen Ovale
Mitral Valvular Disease
Aortic Valvular Disease
Patent Ductus Arteriosus
Ventricular Septal Defects
Others

By End-user

Hospitals
Cardiac Centers
Ambulatory Surgical Centers

Companies Profiled

Abbott Laboratories
Medical Technology Est.
Biomerics
Comed BV
CardioKinetix
Edwards Lifesciences Corporation
Cryolife Inc.
Medtronic plc
Braile Biomedica
Micro Interventional Devices Inc.
Boston Scientific Corporation
LivaNova PLC
St. Jude Medical Inc.
JenaValve Technology Inc.
ST. JUDE MEDICAL

For more information about this report visit https://www.researchandmarkets.com/r/wvemen

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets